Zimmer Biomet Holdings Inc (ZBH) : South Texas Money Management Ltd reduced its stake in Zimmer Biomet Holdings Inc by 26.63% during the most recent quarter end. The investment management company now holds a total of 7,832 shares of Zimmer Biomet Holdings Inc which is valued at $1,021,528 after selling 2,843 shares in Zimmer Biomet Holdings Inc , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Zimmer Biomet Holdings Inc makes up approximately 0.06% of South Texas Money Management Ltd’s portfolio.
Other Hedge Funds, Including , Thompson Investment Management reduced its stake in ZBH by selling 2,655 shares or 7.73% in the most recent quarter. The Hedge Fund company now holds 31,685 shares of ZBH which is valued at $4,132,675. Zimmer Biomet Holdings Inc makes up approx 0.81% of Thompson Investment Management’s portfolio.Greylin Investment Mangement Inc reduced its stake in ZBH by selling 900 shares or 13.98% in the most recent quarter. The Hedge Fund company now holds 5,540 shares of ZBH which is valued at $679,647. Zimmer Biomet Holdings Inc makes up approx 0.15% of Greylin Investment Mangement Inc’s portfolio. Oakbrook Investments sold out all of its stake in ZBH during the most recent quarter. The investment firm sold 9,875 shares of ZBH which is valued $1,229,240.John G Ullman Associates Inc reduced its stake in ZBH by selling 100 shares or 0.76% in the most recent quarter. The Hedge Fund company now holds 13,010 shares of ZBH which is valued at $1,619,485. Zimmer Biomet Holdings Inc makes up approx 0.32% of John G Ullman Associates Inc’s portfolio.Alpha Windward reduced its stake in ZBH by selling 93 shares or 5.56% in the most recent quarter. The Hedge Fund company now holds 1,581 shares of ZBH which is valued at $197,451. Zimmer Biomet Holdings Inc makes up approx 0.14% of Alpha Windward’s portfolio.
Zimmer Biomet Holdings Inc opened for trading at $130.62 and hit $131.08 on the upside on Thursday, eventually ending the session at $130.91, with a gain of 0.37% or 0.48 points. The heightened volatility saw the trading volume jump to 9,69,225 shares. Company has a market cap of $26,082 M.
On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.
Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .Zimmer Biomet Holdings Inc was Initiated by Guggenheim to “Neutral” on Jun 9, 2016.
Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.